|
|
|
|
|
|
| Open:
|
0.27 |
|
Volume:
|
914 |
| High:
|
0.29 |
|
52Wk High:
|
1.14 |
| Low:
|
0.26 |
|
52Wk Low:
|
0.20 |
|
|
|
|
|
|
|
|
|
|
|
14 Rue Kleberg
CH-1201 Geneva, , SZ
|
|
In Vitro and In Vivo Diagnostic Substances |
| |
|
|
|
 |
 |
|
 |
|
Free Registration enables all site features including Email Alerts, RSS Feeds, Charts & Reports, SEC Filings, and Executive & Company Profiles.
|
 |
 |
 |
 |
|
|
 |
|
 |
|
|
|
|
Board Member Report includes all current and historical board members, their board committees, whether they are the chair of each committee, the date they became a member of the board and their Job Title if they are also an executive of the firm. Also, you can create an email alert for any board member right from the Board Member report!
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEC filings are made available through
SECFilings.com – our free SEC filings portal with e-mail alert
and RSS capabilities. Clicking on the links to the left will bring you to the
corresponding page on SECFilings.com where you can login with your
ExecutiveDisclosure.com username and password to instantly view filings and
setup e-mail or RSS alerts.
|
|
 |
 |
 |
|
|
|
|
Company Average Compensation vs. Average Compensation for all Same Market Cap Companies in Same Industry chart compares the average pay for the company against all companies in the same industry and market cap using actual dollar figures.
|
|
|
|
|
|
 |
|
 |
|
|
 |
|
|
|
|
Company Average Compensation vs. Industry Average Compensation chart compares the average pay for the company against all companies in the same industry using actual dollar figures, making it easy to see how the current company's compensation practices compare against the industry average.
|
|
|
|
|
|
|
|
|
|
|
|
Company Average Compensation % Trend vs. Company Stock Prices % Trend chart compares the year over year percentage change in the average compensation package against the year over year percentage change in the company's stock price.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| On January 25, 2008, Sun World Partners, Inc. appointed Mr. Ron Lizee as a member of its Board of Directors. Mr. Lizee was also named as Chief Financial Officer of Sun World Partners, Inc. Mr. Lizee is a Director of Acrongenomics Inc. as well as the... (Read
more) |
|
01/25/2008
0.00 |
|
|
|
|
| |
|
|
|
|
| Platon Tzouvalis, M.Sc., was appointed Vice President of our company on February 14, 2006 and subsequently as the President on October 5, 2006. As a Biochemist and ex-Abbott Laboratories Associate, he is an experienced pharmaceutical industry... (Read
more) |
|
02/14/2006
02/14/2006
615150.00 |
|
|
|
|
| |
|
|
|
|
| Dr. Topoglidis was appointed as Chief Technology Officer, as a director of our company and to the Scientific Advisory Board on February 24, 2006. He received his Bachelor"s of Science from King"s College (University of London) in 1996, his MSc in... (Read
more) |
|
02/24/2006
02/24/2006
332400.00 |
|
|
|
|
| |
|
|
|
|
| Dr. Manolis has been one of our board members since 2006. He received his B.Sc. from University of Illinois at Chicago and his Medical Degree from Southern Illinois University Medical School in 1991. He completed his general surgery residency at the... (Read
more) |
|
2006
|
|
|
|
|
| |
|
|
|
|
| Dr. Goundis was appointed as our Chief Executive Officer on September 3, 2007. Dr. Goundis holds a Ph.D. in Biochemistry from the University of Oxford, a B.Sc. in Chemistry/Biochemistry from the University of London and a Certificate in Investment... (Read
more) |
|
09/03/2007
278658.00 |
|
|
|
|
| |
|
|
|
|
| On September 2, 2008, the Company announced the immediate appointment of Dr. Kailash C. Sharma as a consultant to the Company and as a member of the Scientific Advisory Board. Dr. Sharma has over 25 years of clinical experience in the areas of... (Read
more) |
|
09/02/2008
|
|
|
|
|
|
|
|
|